Published April 23, 2021
| Version 2.0
Project milestone
Open
Identifying new ligands for the SARS-CoV-2 Macrodomain by Fragment Screening and Multi-temperature Crystallography
Description
Macrodomain is a compelling target for SARS-CoV-2, but there are no inhibitors (or even starting points for inhibitors). The QCRG Structural Biology Consortium performed a crystallographic fragments screen, identifying a few small molecules to kick-start our work to develop an inhibitor. Our friends in the UK, Ivan Ahel’s lab and X-Chem, did something similar and found even more fragment starting points. We are releasing the data together!
This record (see README file) has the data available here: https://fraserlab.com/macrodomain/ and published here: https://pubmed.ncbi.nlm.nih.gov/33853786/
Files
macrodomain.zip
Files
(632.7 MB)
Name | Size | Download all |
---|---|---|
md5:7e114a9038057f2ced57ecdabb1a769a
|
1.6 MB | Preview Download |
md5:5b53f87e16588241f36f2e53414a8d80
|
631.1 MB | Preview Download |
Additional details
Related works
- Is derived from
- https://fraserlab.com/macrodomain/ (URL)
- https://github.com/fraser-lab/fraser-lab.github.io/tree/master/macrodomain (URL)